Stocks and Investing Stocks and Investing
Thu, October 15, 2020
Wed, October 14, 2020
Tue, October 13, 2020
Mon, October 12, 2020

Raghuram Selvaraju Maintained (BBIO) at Strong Buy with Increased Target to $53 on, Oct 12th, 2020


Published on 2024-10-27 14:19:07 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Maintained "BridgeBio Pharma, Inc." (BBIO) at Strong Buy with Increased Target from $50 to $53 on, Oct 12th, 2020.

Raghuram has made no other calls on BBIO in the last 4 months.



There is 1 other peer that has a rating on BBIO. Out of the 1 peers that are also analyzing BBIO, all agrees with Raghuram's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Geoff Meacham of "B of A Securities" Initiated at Hold and Held Target at $38 on, Thursday, June 25th, 2020